Emi Kamiyama Selected Research

Erlotinib Hydrochloride (CP 358,774)

1/2017

Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emi Kamiyama Research Topics

Disease

4	Neoplasms (Cancer) 11/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Animal Disease Models 05/2012
1	Arthritis (Polyarthritis) 05/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2012
1	Adenocarcinoma 01/2010

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2009 - 12/2007
1	Ritonavir (Norvir)FDA Link 11/2021
1	trastuzumab deruxtecanIBA 11/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	AntigensIBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Erythropoietin FDA Link 01/2019
1	firuglipelIBA 08/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	patritumabIBA 01/2017
1	CS-2100IBA 05/2012
1	Digoxin (Digitek)FDA LinkGeneric 01/2010
1	Adenosine Triphosphatases (ATPase)IBA 01/2010
1	Verapamil (Calan)FDA LinkGeneric 01/2010
1	Multidrug Resistance-Associated Protein 2IBA 09/2009
1	olmesartanIBA 12/2007
1	Multidrug Resistance-Associated ProteinsIBA 12/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2017